Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Stephanie M. Hamilton"'
Autor:
Alexander L Greninger, Som S Chatterjee, Liana C Chan, Stephanie M Hamilton, Henry F Chambers, Charles Y Chiu
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149541 (2016)
Fifth-generation cephalosporins, ceftobiprole and ceftaroline, are promising drugs for treatment of bacterial infections from methicillin-resistant Staphylococcus aureus (MRSA). These antibiotics are able to bind native PBP2a, the penicillin-binding
Externí odkaz:
https://doaj.org/article/546280846f3141b3bc0985091616d8b2
Autor:
Zhi Li, Dennis L Stevens, Stephanie M Hamilton, Tanyalak Parimon, Yongsheng Ma, Angela M Kearns, Richard W Ellis, Amy E Bryant
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27246 (2011)
In 2008, an unusual strain of methicillin-sensitive Staphylococcus aureus (MSSA68111), producing both Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1), was isolated from a fatal case of necrotizing pneumonia. Because PVL/TS
Externí odkaz:
https://doaj.org/article/49b31a718fef4f169b8d81bf50b88b6f
Autor:
Natalie C. J. Strynadka, Lindsay D. Eltis, Som S. Chatterjee, J.A.N. Alexander, Stephanie M. Hamilton, Henry F. Chambers
Methicillin-resistant Staphylococcus aureus (MRSA) causes serious community-acquired and nosocomial infections worldwide. MRSA strains are resistant to a variety of antibiotics, including the classic penicillin and cephalosporin classes of β-lactams
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb49d8573091928d97777112e35cf22
https://europepmc.org/articles/PMC6314119/
https://europepmc.org/articles/PMC6314119/
Autor:
Binh An Diep, Li Basuino, Henry F. Chambers, Som S. Chatterjee, Liana C. Chan, Stephanie M. Hamilton
Publikováno v:
Antimicrobial agents and chemotherapy, vol 59, iss 5
The role of mecA mutations in conferring resistance to ceftobiprole and ceftaroline, cephalosporins with anti-methicillin-resistant Staphylococcus aureus (MRSA) activity, was determined with MRSA strains COL and SF8300. The SF8300 ceftaroline-passage
Autor:
Marilyn Chung, Som S. Chatterjee, Eun Ju Choo, Li Basuino, Anatoly Severin, Natalie C. J. Strynadka, J. Andrew N. Alexander, Thaina Miranda da Costa, Stephanie M. Hamilton, Henry F. Chambers, Alexander Tomasz, Sandra Aedo
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Penicillin-binding protein 4 (PBP4), a nonessential, low-molecular-weight penicillin-binding protein of Staphylococcus aureus , has been implicated in low-level resistance to β-lactam antibiotics, although the mechanism is unknown. Mutations in PBP4
Publikováno v:
Veterinary anaesthesia and analgesia. 30(2)
Ketamine, a noncompetitive NMDA receptor antagonist, has been shown to provide analgesia in some species. To target the NMDA receptor specifically and to potentially minimize some untoward side-effects, ketamine had been used epidurally. The objectiv
Publikováno v:
Journal of Infectious Diseases. 209:1429-1435
The annual incidence of invasive group A streptococcal (GAS) infections in the United States remains at 3.5/100 000 population per year, and mortality ranges between 30% and 60% (reviewed in [1]). In the approximately 50% of patients lacking an obvio
Publikováno v:
Clinical Infectious Diseases. 57:870-876
Puerperal sepsis caused by group A Streptococcus (GAS) remains an important cause of maternal and infant mortality worldwide, including countries with modern antibiotic regimens, intensive care measures and infection control practices. To provide ins
Publikováno v:
Antimicrobial agents and chemotherapy. 60(7)
Beta-lactams enhance the in vitro activity of daptomycin against methicillin-resistant strains of Staphylococcus aureus . Experiments were performed in a rabbit model of aortic valve endocarditis caused by methicillin-resistant daptomycin-nonsuscepti
Autor:
Richard L. Lieber, Clifford R. Bayer, Amy E. Bryant, Stephanie M. Hamilton, Dennis L. Stevens
Publikováno v:
The Journal of Infectious Diseases. 198:1692-1698
BACKGROUND Myonecrosis due to group A streptococci (GAS) often develops at sites of nonpenetrating muscle injury, and nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the severity of these cryptic infections. We have previously shown that G